Story thread · 2 reports / 2 sources
Eli Lilly is partnering with China's InnoCare on a drug deal worth up to $3.35 billion
qz.com · 4h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
Lilly will pay $100 million upfront to work with the Beijing-based biotech on as many as five undisclosed drug targets
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.